

Search

EN

Back

Morgan Stanley Lifts Hengrui Medicine Target to HK$92 Despite Profit Cuts

Back

Stock NewsThemesMorgan Stanley Lifts Hengrui Medicine Target to HK$92 Despite Profit Cuts

Morgan Stanley Lifts Hengrui Medicine Target to HK$92 Despite Profit Cuts

Edgen Stock·Jan 27 2026, 16:09

Share to

Share to

Copy link

HENGRUI PHARMA-0.36%

source:

[1] Big Bank: Morgan Stanley Lowers Hengrui Medicine (01276.HK) Revenue and Net Profit Forecasts, Raises Target Price to 92 HKD

Recommend

Apple Stock Climbs as Investors Shun Big Tech's $650B AI SpendingFeb 18 2026, 00:32 Similarweb Swings to Profit, Beating Q4 EstimatesFeb 17 2026, 23:58 Hormel Sells Turkey Business, Reaffirms 2026 GuidanceFeb 17 2026, 23:57

Hot News

Tesla Produces First Cybercab, Advancing Robotaxi NetworkFeb 18 2026, 01:06

Hecla Mining Q4 EPS Soars 375%, Crushing EstimatesFeb 18 2026, 00:59

Caterpillar Acquires RPMGlobal to Expand Mining Software UnitFeb 18 2026, 00:58

Software Firms Release Early Data to Counter AI Debt RoutFeb 18 2026, 00:38

Features

AI Copilot for Stock & Crypto

Price Prediction

Fundraise Tracker

Crypto Comparison

Resources

Market

Terms of Use Privacy Policy Sitemap

© 2026 Finture Development Limited. All rights reserved